Drugs Made In America Acquisition (DMII) Assets Average (2025)
Drugs Made In America Acquisition (DMII) posted quarterly Assets Average of $503.0 million for Q4 2025, up 100.73% quarter-over-quarter from $250.6 million in Q3 2025.
Drugs Made In America Acquisition (DMII) Assets Average (2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Assets Average for 1 consecutive years, with $503.0 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Assets Average changed N/A year-over-year to $503.0 million; the TTM figure through Dec 2025 stood at $503.0 million (changed N/A YoY), while the FY2025 annual figure was $252.5 million, changed N/A from the prior year.
- Assets Average rose to $503.0 million in Q4 2025 per DMII's latest filing, from $250.6 million in the prior quarter.
- Across five years, Assets Average topped out at $503.0 million in Q4 2025 and bottomed at $250.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 260.40 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 244.76 Mn |
| 3 | Drugs Made In America Acquisition | 506.00 Mn | 506.00 Mn | - | 509.53 Mn |
| 4 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | 460.97 Mn |
| 5 | New Providence Acquisition Corp. III | 401.18 Mn | 401.18 Mn | - | 313.26 Mn |
| 6 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 203.86 Mn |
| 7 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 246.68 Mn |
| 8 | Bold Eagle Acquisition | 391.94 Mn | 391.94 Mn | - | 273.89 Mn |
| 9 | Pioneer Acquisition I | 390.89 Mn | 653.32 Mn | - | 262.37 Mn |
| 10 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 313.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 502.98 Mn |
| Sep 30, 2025 | 250.57 Mn |